The neuroprotective role of melatonin in neurological disorders

Melatonin is a neurohormone secreted from the pineal gland and has a wide‐ranging regulatory and neuroprotective role. It has been reported that melatonin level is disturbed in some neurological conditions such as stroke, Alzheimer's disease, and Parkinson's disease, which indicates its involvement in the pathophysiology of these diseases. Its properties qualify it to be a promising potential therapeutic neuroprotective agent, with no side effects, for some neurological disorders. This review discusses and localizes the effect of melatonin in the pathophysiology of some diseases.

• Publication year

  2018

• Venue

  Journal of Neuroscience Research

• Publication date

  2018-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/jnr.24220PMID 29498103PMCID 6001545
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The neuroprotective role of melatonin in neurological disorders

  2018cited by this paper
• Lipid raft ER signalosome malfunctions in menopause and Alzheimer's disease.

  2017cited by this paper
• Mechanisms of Melatonin in Alleviating Alzheimer’s Disease

  2017cited by this paper
• Gas chromatographic-mass spectrometric determination of glycosides without prior hydrolysis.

  2017cited by this paper
• Nicotine from cigarette smoking and diet and Parkinson disease: a review

  2017cited by this paper
• Mitochondrial dynamics in Parkinson's disease: a role for α-synuclein?

  2017cited by this paper
• Integrated late onset Alzheimer's disease (LOAD) susceptibility genes: Cholesterol metabolism and trafficking perspectives.

  2017cited by this paper
• SORL1 rs1699102 polymorphism modulates age‐related cognitive decline and gray matter volume reduction in non‐demented individuals

  2017cited by this paper
• Intake of dairy foods and risk of Parkinson disease

  2017cited by this paper
• Molecular and Cellular Basis of Neurodegeneration in Alzheimer’s Disease

  2017cited by this paper
• Neuroprotective Mechanisms of Melatonin in Hemorrhagic Stroke

  2017cited by this paper
• Melatonin receptors: distribution in mammalian brain and their respective putative functions

  2017cited by this paper
• Melatonin as an Antioxidant for Stroke Neuroprotection

  2016cited by this paper
• Dietary Approaches and Supplements in the Prevention of Cognitive Decline and Alzheimer's Disease.

  2016cited by this paper
• Protective effect of melatonin on soluble Aβ1–42-induced memory impairment, astrogliosis, and synaptic dysfunction via the Musashi1/Notch1/Hes1 signaling pathway in the rat hippocampus

  2016cited by this paper
• Decreased Plasma Aβ in Hyperlipidemic APPSL Transgenic Mice Is Associated with BBB Dysfunction

  2016cited by this paper
• Melatonin protects against oxygen and glucose deprivation by decreasing extracellular glutamate and Nox-derived ROS in rat hippocampal slices.

  2016cited by this paper
• Melatonin Preserves Blood-Brain Barrier Integrity and Permeability via Matrix Metalloproteinase-9 Inhibition

  2016cited by this paper
• Melatonin attenuates impairments of structural hippocampal neuroplasticity in OXYS rats during active progression of Alzheimer's disease‐like pathology

  2015cited by this paper
• Melatonin Counteracts at a Transcriptional Level the Inflammatory and Apoptotic Response Secondary to Ischemic Brain Injury Induced by Middle Cerebral Artery Blockade in Aging Rats

  2015cited by this paper
• Melatonin reduces excitotoxic blood-brain barrier breakdown in neonatal rats.

  2015cited by this paper
• Melatonin: Physiological effects in humans.

  2015cited by this paper
• Omega-3 Fatty Acids in Early Prevention of Inflammatory Neurodegenerative Disease: A Focus on Alzheimer's Disease

  2015cited by this paper
• Melatonin Attenuates Memory Impairment, Amyloid-β Accumulation, and Neurodegeneration in a Rat Model of Sporadic Alzheimer’s Disease

  2015cited by this paper
• Melatonin ameliorates amyloid beta‐induced memory deficits, tau hyperphosphorylation and neurodegeneration via PI3/Akt/GSk3β pathway in the mouse hippocampus

  2015cited by this paper
• Melatonin renders neuroprotection by protein kinase C mediated aquaporin-4 inhibition in animal model of focal cerebral ischemia.

  2014cited by this paper
• Melatonin use for neuroprotection in perinatal asphyxia: a randomized controlled pilot study

  2014cited by this paper
• The Beneficial Effect of Melatonin in Brain Endothelial Cells against Oxygen-Glucose Deprivation Followed by Reperfusion-Induced Injury

  2014cited by this paper
• Non-motor symptoms of Parkinson's disease A review…from the past.

  2014cited by this paper
• Circadian melatonin rhythm and excessive daytime sleepiness in Parkinson disease.

  2014cited by this paper
• Alterations in the time course of expression of the Nox family in the brain in a rat experimental cerebral ischemia and reperfusion model: effects of melatonin

  2014cited by this paper
• The oxidative stress hypothesis in Alzheimer's disease.

  2013cited by this paper
• Melatonin regulates the calcium‐buffering proteins, parvalbumin and hippocalcin, in ischemic brain injury

  2012cited by this paper
• Vascular factors and epigenetic modifications in the pathogenesis of Alzheimer's disease.

  2012cited by this paper
• Mitochondrial- and Endoplasmic Reticulum-Associated Oxidative Stress in Alzheimer's Disease: From Pathogenesis to Biomarkers

  2012cited by this paper
• Effect of melatonin on α-synuclein self-assembly and cytotoxicity.

  2012cited by this paper
• Therapeutic application of melatonin in mild cognitive impairment.

  2012cited by this paper
• Alzheimer’s disease and type 2 diabetes: the association study of polymorphisms in tumor necrosis factor-alpha and apolipoprotein E genes

  2012cited by this paper
• Bright Light Therapy in Parkinson's Disease: An Overview of the Background and Evidence

  2012cited by this paper
• Melatonin ameliorates neural function by promoting endogenous neurogenesis through the MT2 melatonin receptor in ischemic-stroke mice.

  2012cited by this paper
• Oxidative Stress in Ischemic Brain Damage: Mechanisms of Cell Death and Potential Molecular Targets for Neuroprotection

  2011cited by this paper
• Amyloid-β and tau — a toxic pas de deux in Alzheimer's disease

  2011cited by this paper
• Epidemiology and etiology of Parkinson’s disease: a review of the evidence

  2011cited by this paper
• Systems neuroscience: The stress of dieting

  2011cited by this paper
• Melatonin MT1 and MT2 receptor expression in Parkinson's disease.

  2010cited by this paper
• Melatonin or silymarin reduces maneb‐ and paraquat‐induced Parkinson’s disease phenotype in the mouse

  2010cited by this paper
• Anti-Amyloidogenic and Anti-Apoptotic Role of Melatonin in Alzheimer Disease

  2010influential reference
• Future directions for immune modulation in neurodegenerative disorders: focus on Parkinson’s disease

  2010cited by this paper
• Significance of High Levels of Endogenous Melatonin in Mammalian Cerebrospinal Fluid and in the Central Nervous System

  2010influential reference
• Role of Oxidative Stress in the Progression of Alzheimer's Disease

  2010cited by this paper
• Changes of some oxidative stress markers in the serum of patients with mild cognitive impairment and Alzheimer's disease.

  2010cited by this paper
• Melatonin Metabolism in the Central Nervous System

  2010cited by this paper
• Melatonin in grape, not just a myth, maybe a panacea

  2009cited by this paper
• ELEVATION OF MATRIX METALLOPROTEINASES 3 AND 9 IN CEREBROSPINAL FLUID AND BLOOD IN PATIENTS WITH SEVERE TRAUMATIC BRAIN INJURY

  2009cited by this paper
• Role of melatonin in neurodegenerative diseases

  2009cited by this paper
• Kynuramines, metabolites of melatonin and other indoles: the resurrection of an almost forgotten class of biogenic amines

  2009cited by this paper
• Melatonin alters cell death processes in response to age‐related oxidative stress in the brain of senescence‐accelerated mice

  2009cited by this paper
• Cranial irradiation‐induced inhibition of neurogenesis in hippocampal dentate gyrus of adult mice: attenuation by melatonin pretreatment

  2009cited by this paper
• Melatonin ameliorates high fat diet‐induced diabetes and stimulates glycogen synthesis via a PKCζ‐Akt‐GSK3β pathway in hepatic cells

  2009cited by this paper
• Global and regional causes of death.

  2009cited by this paper
• The changing biological roles of melatonin during evolution: from an antioxidant to signals of darkness, sexual selection and fitness

  2009influential reference
• Melatonin reduces experimental subarachnoid hemorrhage‐induced oxidative brain damage and neurological symptoms

  2009cited by this paper
• Mitochondrial dynamics in Parkinson's disease.

  2009cited by this paper
• Bioactivity of Grape Chemicals for Human Health

  2009cited by this paper
• Protection against cognitive deficits and markers of neurodegeneration by long‐term oral administration of melatonin in a transgenic model of Alzheimer disease

  2009cited by this paper
• Long‐term melatonin administration protects brain mitochondria from aging

  2009cited by this paper
• Phytomelatonin: a review.

  2009cited by this paper
• The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics

  2009cited by this paper
• Melatonin reduces body weight in goldfish (Carassius auratus): effects on metabolic resources and some feeding regulators

  2008cited by this paper
• Parkinson’s disease: genetic versus toxin‐induced rodent models

  2008cited by this paper
• Variation in CYP1A2 activity and its clinical implications: influence of environmental factors and genetic polymorphisms.

  2008cited by this paper
• Endogenous Melatonin Increases in Cerebrospinal Fluid of Patients after Severe Traumatic Brain Injury and Correlates with Oxidative Stress and Metabolic Disarray

  2008cited by this paper
• Update in the epidemiology of Parkinson's disease

  2008cited by this paper
• Melatonin impairs NADPH oxidase assembly and decreases superoxide anion production in microglia exposed to amyloid‐β1–42

  2008cited by this paper
• The cost of cerebral ischaemia.

  2008cited by this paper
• Parkinson's disease--Part 1: Pathophysiology, symptoms, burden, diagnosis, and assessment.

  2008cited by this paper
• Melatonin protects from the long‐term consequences of a neonatal hypoxic‐ischemic brain injury in rats

  2008cited by this paper
• Evaluation of potential pro‐survival pathways regulated by melatonin in a murine senescence model

  2008influential reference
• Peripheral Oxidative Damage in Mild Cognitive Impairment and Mild Alzheimer's Disease

  2008cited by this paper
• Intraocular microinjections repair experimental Parkinson's disease.

  2008cited by this paper
• Formation of Toxic Oligomeric α-Synuclein Species in Living Cells

  2008cited by this paper
• Malondialdehyde, carbonyl proteins and albumin-disulphide as useful oxidative markers in mild cognitive impairment and Alzheimer's disease

  2008cited by this paper
• Primary and Secondary Features of Parkinson's Disease Improve with Strategic Exposure to Bright Light: A Case Series Study

  2007cited by this paper
• Neuroinflammatory mechanisms in Parkinson's disease: potential environmental triggers, pathways, and targets for early therapeutic intervention.

  2007cited by this paper
• Melatonin attenuates arsenite‐induced apoptosis in rat brain: involvement of mitochondrial and endoplasmic reticulum pathways and aggregation of α‐synuclein

  2007cited by this paper
• Cultured rat cortical astrocytes synthesize melatonin: absence of a diurnal rhythm

  2007cited by this paper
• Bright light therapy in Parkinson's disease: A pilot study

  2007cited by this paper
• Melatonin protects against rotenone‐induced oxidative stress in a hemiparkinsonian rat model

  2007cited by this paper
• One molecule, many derivatives: A never‐ending interaction of melatonin with reactive oxygen and nitrogen species?

  2007influential reference
• Ventricular cerebrospinal fluid melatonin concentrations investigated with an endoscopic technique

  2007cited by this paper
• Intravenous administration of melatonin reduces the intracerebral cellular inflammatory response following transient focal cerebral ischemia in rats

  2007cited by this paper
• Pineal and cortical melatonin receptors MT1 and MT2 are decreased in Alzheimer's disease.

  2006cited by this paper
• Melatonin decreases neurovascular oxidative/nitrosative damage and protects against early increases in the blood–brain barrier permeability after transient focal cerebral ischemia in mice

  2006cited by this paper
• Oxidative Stress Induces Intralysosomal Accumulation of Alzheimer Amyloid β‐Protein in Cultured Neuroblastoma Cells

  2006cited by this paper
• Lewy bodies.

  2006cited by this paper
• Effect of caffeine intake 12 or 24 hours prior to melatonin intake and CYP1A2*1F polymorphism on CYP1A2 phenotyping by melatonin.

  2006cited by this paper
• Melatonin as a cytoskeletal modulator: implications for cell physiology and disease

  2006influential reference
• Distribution of MT1 melatonin receptor immunoreactivity in the human hypothalamus and pituitary gland: Colocalization of MT1 with vasopressin, oxytocin, and corticotropin‐releasing hormone

  2006cited by this paper
• The role of free radicals in cerebral hypoxia and ischemia.

  2005cited by this paper
• Functional MT1 and MT2 melatonin receptors in mammals

  2005influential reference

• Melatonin protects against fluoride-induced developmental neurotoxicity by alleviating abnormal mitophagy and apoptosis via the PINK1/Parkin pathway.

  2026cites this paper
• E2F Transcription Factor 8 Contributes to the Pathogenesis of Alzheimer's Disease Accompanied with Decreased Expression of Matrix Metalloproteinase-9 and B-cell Lymphoma 2.

  2026cites this paper
• Divergence in Cu(II)- and Zn(II)-Based Coordination Polymers: The Sensing of Melatonin and Tryptophan, and Their Anticancer Activity.

  2026cites this paper
• Microfabricated Neural Biosensors for Detection of Neurotransmitters, Biomarkers, and Small Molecules: Emerging Trends on Self‐Sustained Systems and Energy Harvesting

  2026cites this paper
• Melatonin Alleviates Cerebral Ischemia/Reperfusion Injury by Mitigating AIM2-Mediated PANoptosis in Ischemic Penumbra

  2026cites this paper
• Content of Phytomelatonin in Acorns (Quercus sp.) in Its Possible Use as a Phytogenic in Animal Nutrition

  2025cites this paper
• The effect of melatonin on sleep quality and daytime sleepiness in Parkinson's disease: A systematic review and meta-analysis of randomized placebo-controlled trials.

  2025cites this paper
• Melatonin alleviates neuroinflammation in ischemic stroke by regulating cGAS-mediated microglial pyroptosis signaling.

  2025cites this paper
• Melatonin Alleviates Streptozotocin-Induced Neuropathic Pain in Rat Model: Involvement of Noradrenergic Receptor Pathways

  2025cites this paper
• The Interplay Between Melatonin and Nitric Oxide: Mechanisms and Implications in Stroke Pathophysiology

  2025cites this paper
• Melatonin Deficits Result in Pathologic Metabolic Reprogramming in Differentiated Neurons

  2025cites this paper
• Discovery of Novel 2‐Oxindoles as Compounds with Antiglaucoma Activity

  2025cites this paper
• The Efficacy of Combined Melatonin and Methylphenidate in Attenuating Pyroptosis and Cognitive Deficits Induced by Aluminum Chloride Administration in BALB/C Mice

  2025cites this paper
• Impact of Experimental Congenital Toxoplasmosis on the Thyroid Gland: Histopathological and Immunobiochemical Indices Assessment

  2025cites this paper
• Repurposing Melatonin in dual-mode for Wilson disease therapy as a Copper Chelator and an antioxidant agent

  2025cites this paper
• Pinealectomy-Induced Neuroinflammation Varies with Age in Rats

  2025cites this paper
• Therapeutic potential of melatonin in management of diabetic mellitus and diabetic neuropathic pain: Underlying mechanisms, challenges and future perspectives.

  2025cites this paper
• Repurposing melatonin's therapeutic potential in Wilson disease: Addressing copper overload and redox imbalance

  2025cites this paper
• Melatonin Mitigates Acidosis-Induced Neuronal Damage by Up-Regulating Autophagy via the Transcription Factor EB

  2025cites this paper
• Hypoxia reverses the early anti-inflammatory microglial response to the β-amyloid peptide: mitochondrial involvement and beneficial roles of melatonin and naringenin

  2025cites this paper
• The role of the tryptophan metabolites in gut microbiota-brain axis and potential treatments: a focus on ischemic stroke

  2025cites this paper
• Different light color temperatures in the morning on the effectiveness of rehabilitation training in patients with ischemic stroke: a prospective, single-center, randomized controlled clinical trial

  2025cites this paper
• Protective effects of melatonin on stroke in diabetic mice: central and peripheral inflammation modulation

  2025cites this paper
• Pharmacological inhibition of the RhoA pathway by melatonin reduces viral replication and proinflammatory response against ZIKV and DENV-4 neuroinfections

  2025cites this paper
• Production, Mechanisms, and Therapeutic Strategies of Tryptophan Metabolites in CNS Diseases

  2025cites this paper
• Melatonin Overexpression in the Management of Alzheimer's Disease: Therapeutic Exploration.

  2025cites this paper
• Association of Circadian Rhythm Biomarkers and Ambulatory Blood Pressure Monitoring With Prognosis and Outcome in People With Acute Ischemic Stroke: A Case-Control Study

  2025cites this paper
• Melatonin—A Powerful Antioxidant in Neurodegenerative Diseases

  2025cites this paper
• Insomnia in Parkinson’s Disease: Causes, Consequences, and Therapeutic Approaches

  2024cites this paper
• Blunted Melatonin Circadian Rhythm in Parkinson’s Disease: Express Bewilderment

  2024cites this paper
• Circadian Effects of Melatonin Receptor-Targeting Molecules In Vitro

  2024cites this paper
• Phytomelatonin: From Intracellular Signaling to Global Horticulture Market

  2024cites this paper
• Effect of Aluminum Oxide and Polydimethylsiloxane Composites Modified with Melatonin and Lithium on the Expression of LYVE-1 and HIF-1α in db/db Mouse Brain

  2024cites this paper
• Melatonin’s Impact on Cytokine Storm and Modulation of Purinergic Receptors for COVID-19 Prognosis: A Mental Health Perspective

  2024cites this paper
• Exploring the impact of melatonin and omega-3, individually and in combination, on cognitive function, histological changes, and oxidant-antioxidant balance in male rats with dorsal CA1 hippocampal lesions.

  2024cites this paper
• Melatonin Ameliorates Post-Stroke Cognitive Impairment in Mice by Inhibiting Excessive Mitophagy

  2024cites this paper
• Effect of melatonin on postoperative cognitive function in elderly patients submitted to transurethral resection of the prostate under spinal anesthesia

  2024cites this paper
• The Main Risk Factors in Type 2 Diabetes for Cognitive Dysfunction, Depression, and Psychosocial Problems: A Systematic Review

  2024cites this paper
• Biological Metal–Organic Framework-Embedded MXene Nanocomposite as a Wearable Transducer Patch for Real-Time Monitoring of the Sleep Hormone

  2024cites this paper
• A Review of the Common Neurodegenerative Disorders: Current Therapeutic Approaches and the Potential Role of Bioactive Peptides.

  2024cites this paper
• Exploring the epigenome to identify biological links between the urban environment and neurodegenerative disease: an evidence review

  2024cites this paper
• Melatonin attenuates liver injury in arsenic‐treated rats: The potential role of the Nrf2/HO‐1, apoptosis, and miR‐34a/Sirt1/autophagy pathways

  2024cites this paper
• Exploring melatonin’s therapeutic potential in neurological disorders: a review of current evidence

  2024cites this paper
• Neuroprotective effects of maternal melatonin administration in early-onset placental insufficiency and fetal growth restriction

  2024cites this paper
• Melatonin as a potential treatment option in diabetes complications

  2024cites this paper
• Modulation of neural circuits by melatonin in neurodegenerative and neuropsychiatric disorders

  2024cites this paper
• A Comprehensive Review on the Role of Melatonin's Anesthetic Applications in Pediatric Care

  2024influential citation
• A Clinical, Pharmacological, and Formulation Evaluation of Melatonin in the Treatment of Ocular Disorders—A Systematic Review

  2024cites this paper
• Melatonin secretion patterns are associated with cognitive vulnerability and brain structure in bipolar depression

  2023cites this paper
• Long-Term Effects of Perinatal Exposure to a Glyphosate-Based Herbicide on Melatonin Levels and Oxidative Brain Damage in Adult Male Rats

  2023cites this paper
• Design, synthesis, molecular docking and DFT studies on novel melatonin and isatin based azole derivatives

  2023cites this paper
• Role of Bmal1 and Gut Microbiota in Alzheimer's Disease and Parkinson's Disease Pathophysiology: The Probable Effect of Melatonin on Their Association.

  2023cites this paper
• Protection of Viola odorata L. against neurodegenerative diseases: potential of the extract and major phytoconstituents

  2023cites this paper
• Oxidative stress, the blood–brain barrier and neurodegenerative diseases: The critical beneficial role of dietary antioxidants

  2023cites this paper
• Involvement of Plasma Melatonin in Medication-Overuse Headache: A Cross-Sectional Study

  2023cites this paper
• Melatonin and related compounds as antioxidants.

  2023cites this paper
• Tryptophan Metabolism in Central Nervous System Diseases: Pathophysiology and Potential Therapeutic Strategies

  2023cites this paper
• Melatonin modulates the aggravation of pyroptosis, necroptosis, and neuroinflammation following cerebral ischemia and reperfusion injury in obese rats.

  2023cites this paper
• Melatonin mitigates type 1 diabetes‐aggravated cerebral ischemia‐reperfusion injury through anti‐inflammatory and anti‐apoptotic effects

  2023cites this paper
• Examination of correlations between vitamin D and melatonin levels with sleep among women aged 18-49 years.

  2023cites this paper
• G protein-coupled receptors in neurodegenerative diseases and psychiatric disorders

  2023cites this paper
• Ambient Particulate Matter (PM2.5) exposure contributes to neurodegeneration through the microbiome-gut-brain axis: therapeutic role of melatonin.

  2023cites this paper
• Epigenetic Mechanisms Involved in the Effects of Maternal Hyperhomocysteinemia on the Functional State of Placenta and Nervous System Plasticity in the Offspring

  2023cites this paper
• Radical Scavenging Mechanisms of 1-Arylhydrazone Benzimidazole Hybrids with Neuroprotective Activity.

  2023cites this paper
• Melatonin Activates Anti-Inflammatory Features in Microglia in a Multicellular Context: Evidence from Organotypic Brain Slices and HMC3 Cells

  2023cites this paper
• Co-administration of exercise training and melatonin on the function of diabetic heart tissue: a systematic review and meta-analysis of rodent models

  2023cites this paper
• Melatonin protects against developmental PBDE‐47 neurotoxicity by targeting the AMPK/mitophagy axis

  2023cites this paper
• Changes in the Secretion of Melatonin and Selected Adipokines during the Progression of Parkinson’s Disease—Preliminary Studies

  2023cites this paper
• Epigenetic mechanisms of the maternal hyperhomocysteinemia influence on the placenta functional state and the offspring nervous system plasticity

  2023cites this paper
• Targeting Necroptosis: A Novel Therapeutic Option for Retinal Degenerative Diseases

  2023cites this paper
• Melatonin Supports the Survival of Cholinergic Neurons in Organotypic Brain Slices of the Basal Nucleus of Meynert

  2023cites this paper
• Exploring Links between Pineal Gland Calcification and Central Nervous System Disease

  2023cites this paper
• Influence of hormones in multiple sclerosis: focus on the most important hormones

  2023cites this paper
• Exogenous melatonin alleviates neuropathic pain-induced affective disorders by suppressing NF-κB/ NLRP3 pathway and apoptosis

  2023cites this paper
• The Role of the Serotonin Pathway of Tryptophan Metabolism in the Development of Neuroinflammation in Alzheimer’s Disease

  2023influential citation
• DPP4 valorphin activate NR4As pathway and OPA1 that protect from CoQ10 deficiency from OPA1 dysfunctions and from WMH

  2023cites this paper
• Role of melatonin and quercetin as countermeasures to the mitochondrial dysfunction induced by titanium dioxide nanoparticles.

  2023cites this paper
• Neuroprotective Effect of Melatonin on Sleep Disorders Associated with Parkinson’s Disease

  2023cites this paper
• Melatonin regulates microglial polarization and protects against ischemic stroke-induced brain injury in mice.

  2023cites this paper
• DPP4 Valorphin Activate NR4As Pathway and OPA1 That Protect from CoQ10 Deficiency, OPA1 Dysfunctions and WMH

  2023cites this paper
• Increased Oxidative Stress Markers in Acute Ischemic Stroke Patients Treated with Thrombolytics

  2022cites this paper
• Melatonin attenuates cardiopulmonary toxicity induced by benzo(a)pyrene in mice focusing on apoptosis and autophagy pathways

  2022cites this paper
• Genetic Links Between Melatonin and Neurological Diseases

  2022cites this paper
• Design, synthesis, and evaluation of 8-aminoquinoline-melatonin derivatives as effective multifunctional agents for Alzheimer’s disease

  2022cites this paper
• Chronic Light-Distorted Glutamate-Cortisol Signaling, Behavioral and Histological Markers, and Induced Oxidative Stress and Dementia: An Amelioration by Melatonin.

  2022cites this paper
• Development of Neuroprotective Agents for the Treatment of Alzheimer's Disease Using Conjugates of Serotonin with Sesquiterpene Lactones.

  2022cites this paper
• Role of melatonin in Alzheimer's disease: From preclinical studies to novel melatonin-based therapies.

  2022cites this paper
• Role of melatonin in respiratory diseases (Review)

  2022cites this paper
• Targeting Glioma Cells with Nutraceuticals: Therapeutic Effects Based on Molecular Mechanisms, New Evidence, and Perspectives.

  2022cites this paper
• Neurotoxicity of Bisphenol A and the Impact of Melatonin Administration on Oxidative Stress, ERK/NF-kB Signaling Pathway, and Behavior in Rats

  2022cites this paper
• Melatonin as the Cornerstone of Neuroimmunoendocrinology

  2022cites this paper
• Revisiting the role of melatonin in human melanocyte physiology: A skin context perspective

  2022cites this paper
• The Effect of Melatonin and Exercise on Social Isolation-Related Behavioral Changes in Aged Rats

  2022cites this paper
• The association between pineal gland calcification and intracranial atherosclerotic disease in older adults Asociación entre calcificaciones de la glándula pineal y enfermedad aterosclerótica intracraneal en adultos mayores

  2022cites this paper
• Adropin and MOTS‐c as new peptides: Do levels change in neurodegenerative diseases and ischemic stroke?

  2022cites this paper
• Screening the Efficacy of Melatonin on Neurodegeneration Mediated by Endoplasmic Reticulum Stress, Inflammation, and Oxidative Damage

  2022cites this paper
• Melatonin in Brassicaceae: Role in Postharvest and Interesting Phytochemicals

  2022cites this paper
• EFFECT OF MELATONIN IN POST-STROKE RECOVERY

  2022cites this paper
• CADMA-Chem: A Computational Protocol Based on Chemical Properties Aimed to Design Multifunctional Antioxidants

  2022cites this paper
• Potential Therapeutic Approach of Melatonin against Omicron and Some Other Variants of SARS-CoV-2

  2022cites this paper